CinDome Pharma, a CinRx portfolio company dedicated to advancing a safe, chronic therapy for gastroparesis, announced today that enrollment in the Phase 2 envisionGI trial of deudomperidone (CIN-102) ...

Whether you're sorting out the symptoms of an undiagnosed condition or grappling with the weight of a recent diagnosis, gastroparesis can be a complicated and daunting disease to navigate. You'll ...

WASHINGTON, Dec. 4, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of Vanda's New Drug ...

The FDA requested additional studies be conducted to provide further evidence of efficacy. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Vanda Pharmaceuticals ...

Evoke Pharma, Inc. announced that it has received a Notice of Allowance from the USPTO for a patent application covering the use of its GIMOTI® (metoclopramide) nasal spray in patients with moderate ...

Digestive woes like gastroparesis and IBS, though distinct, cause similar discomfort. Gastroparesis slows stomach emptying, ...

The FDA declined to approve tradipitant for adults with symptoms of gastroparesis, or delayed gastric emptying, drugmaker Vanda Pharmaceuticals announced on Thursday. Support for the neurokinin-1 ...

Tonix Pharmaceuticals launched a campaign to highlight gastroparesis' impact on oral migraine medication absorption, promoting non-oral treatments. Gastroparesis, often comorbid with migraines, ...

Vanda Pharma (NASDAQ:VNDA) shares jumped 19% premarket on Tuesday as the FDA accepted the new drug application (NDA) for tradipitant, an experimental drug for the treatment of gastroparesis.

Eating small frequent meals is among the dietary strategies that could improve gastric emptying. Recommendations include eating small frequent meals, chewing foods well, and limiting insoluble fiber.